Pages that link to "Q38169212"
Jump to navigation
Jump to search
The following pages link to Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches (Q38169212):
Displaying 31 items.
- Precocious Alterations of Brain Oscillatory Activity in Alzheimer's Disease: A Window of Opportunity for Early Diagnosis and Treatment (Q26770751) (← links)
- Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics (Q26784569) (← links)
- Anti-dementia medications: current prescriptions in clinical practice and new agents in progress (Q26795400) (← links)
- Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease (Q26829899) (← links)
- Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease (Q27305174) (← links)
- Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity (Q28601353) (← links)
- BMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer's disease models (Q28829902) (← links)
- Presenilin 1 and Presenilin 2 Target γ-Secretase Complexes to Distinct Cellular Compartments (Q30780773) (← links)
- Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. (Q34431008) (← links)
- Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat (Q34987506) (← links)
- Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice (Q35137488) (← links)
- Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase (Q35772984) (← links)
- Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia (Q35813037) (← links)
- A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease (Q36850925) (← links)
- Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease (Q37665855) (← links)
- Pirinixic acids: flexible fatty acid mimetics with various biological activities (Q38574980) (← links)
- Inhibition of γ-Secretase Leads to an Increase in Presenilin-1. (Q38641308) (← links)
- α-Mangostin decreases β-amyloid peptides production via modulation of amyloidogenic pathway. (Q38827287) (← links)
- Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances (Q38936146) (← links)
- Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease (Q39196662) (← links)
- Emerging amyloid and tau targeting treatments for Alzheimer's disease (Q39296311) (← links)
- Fused Morphlinopyrimidines and Methods of Use Thereof (Q42544939) (← links)
- First in human study with a prodrug of galantamine: Improved benefit-risk ratio? (Q42689680) (← links)
- Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1. (Q47745925) (← links)
- Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer's disease (Q48503329) (← links)
- MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease (Q49491716) (← links)
- Transcriptomic Analysis of Drosophila Mushroom Body Neurons Lacking Amyloid-β Precursor-Like Protein Activity (Q50244311) (← links)
- Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease. (Q55405257) (← links)
- A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease (Q57927766) (← links)
- Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay (Q58696563) (← links)
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement (Q58862961) (← links)